2 studies found for:    18620949 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of the Combination Vemurafenib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Peg-interferon
2 Active, not recruiting Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: pegylated interferon alfa;   Procedure: adjuvant therapy

Indicates status has not been verified in more than two years